Argan director sells 5,000 shares at $360.78

Argan, Inc. director John R. Jeffrey Jr. reported an open-market sale of common stock.

Rhea-AI Filing Summary

Argan, Inc. director John R. Jeffrey Jr. reported an open-market sale of common stock. On January 27, 2026, he sold 5,000 shares of Argan common stock at an average price of $360.78 per share. After this transaction, he held 8,192 shares directly and 8,000 shares indirectly through a John R. Jeffrey IRA.

Insider Trade Summary

Net Seller: 5,000 shares

Net Sell 2 txns

Insider Jeffrey John Ronald Jr.

Role Director

Sold 5,000 shs ($1.80M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$360.78	$1.80M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,192 shares (Direct); Common Stock — 8,000 shares (Indirect, John R. Jeffrey, IRA)

Footnotes (1)

1. F1. On January 27, 2026, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $360.78 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AGX director John R. Jeffrey report?

Director John R. Jeffrey Jr. reported selling 5,000 shares of Argan, Inc. common stock. The sale occurred on January 27, 2026, as an open-market transaction at an average price of $360.78 per share, according to his Form 4 filing.

At what price did John R. Jeffrey sell his AGX shares?

John R. Jeffrey Jr. sold his Argan, Inc. shares at an average price of $360.78 per share. The Form 4 indicates this was an open-market sale of 5,000 common shares completed on January 27, 2026.

How many AGX shares does John R. Jeffrey own after this Form 4 sale?

After the reported sale, John R. Jeffrey Jr. beneficially owned 8,192 Argan, Inc. shares directly. He also held 8,000 additional common shares indirectly through an account titled “John R. Jeffrey, IRA,” as disclosed in the Form 4.

Is John R. Jeffrey a director or officer of Argan, Inc. (AGX)?

John R. Jeffrey Jr. is listed as a director of Argan, Inc. on the Form 4. The filing does not identify him as an officer or 10% owner, but specifically checks the box indicating his role as a director.

Were any AGX shares held indirectly by John R. Jeffrey reported?

Yes. In addition to his directly held shares, the Form 4 shows 8,000 Argan, Inc. common shares indirectly owned. These are held through an IRA account labeled “John R. Jeffrey, IRA,” classified as indirect beneficial ownership.

What was the transaction code used in John R. Jeffrey’s AGX Form 4?

The Form 4 uses transaction code “S” for John R. Jeffrey Jr.’s trade. Code “S” indicates an open-market or privately negotiated sale of non-derivative securities, in this case 5,000 shares of Argan, Inc. common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jeffrey John Ronald Jr.

(Last) (First) (Middle)

C/O ARGAN, INC.

4075 WILSON BOULEVARD, SUITE 440

(Street)

ARLINGTON VA 22203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/27/2026		S		5,000(1)	D	$360.78	8,192	D
Common Stock								8,000	I	John R. Jeffrey, IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On January 27, 2026, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $360.78 per share.

	/s/ John R. Jeffrey, Jr.	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.